Logo image of BSX.CA

BELO SUN MINING CORP (BSX.CA) Stock Fundamental Analysis

TSX:BSX - Toronto Stock Exchange - CA0805581091 - Common Stock - Currency: CAD

0.205  -0.01 (-2.38%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BSX. BSX was compared to 808 industry peers in the Metals & Mining industry. BSX has a great financial health rating, but its profitability evaluates not so good. BSX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BSX has reported negative net income.
BSX had a negative operating cash flow in the past year.
In the past 5 years BSX always reported negative net income.
In the past 5 years BSX always reported negative operating cash flow.
BSX.CA Yearly Net Income VS EBIT VS OCF VS FCFBSX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -40.63%, BSX is doing worse than 61.01% of the companies in the same industry.
BSX's Return On Equity of -47.32% is in line compared to the rest of the industry. BSX outperforms 45.17% of its industry peers.
Industry RankSector Rank
ROA -40.63%
ROE -47.32%
ROIC N/A
ROA(3y)-35.85%
ROA(5y)-26.09%
ROE(3y)-38.88%
ROE(5y)-28.15%
ROIC(3y)N/A
ROIC(5y)N/A
BSX.CA Yearly ROA, ROE, ROICBSX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

BSX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSX.CA Yearly Profit, Operating, Gross MarginsBSX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for BSX has been increased compared to 1 year ago.
The number of shares outstanding for BSX has been increased compared to 5 years ago.
There is no outstanding debt for BSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BSX.CA Yearly Shares OutstandingBSX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BSX.CA Yearly Total Debt VS Total AssetsBSX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 1.63, we must say that BSX is in the distress zone and has some risk of bankruptcy.
BSX has a Altman-Z score (1.63) which is comparable to the rest of the industry.
BSX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.63
ROIC/WACCN/A
WACCN/A
BSX.CA Yearly LT Debt VS Equity VS FCFBSX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

BSX has a Current Ratio of 3.23. This indicates that BSX is financially healthy and has no problem in meeting its short term obligations.
BSX has a Current ratio of 3.23. This is in the better half of the industry: BSX outperforms 65.35% of its industry peers.
A Quick Ratio of 3.23 indicates that BSX has no problem at all paying its short term obligations.
BSX has a Quick ratio of 3.23. This is in the better half of the industry: BSX outperforms 66.46% of its industry peers.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 3.23
BSX.CA Yearly Current Assets VS Current LiabilitesBSX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

BSX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.00%.
EPS 1Y (TTM)-12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BSX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.38% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y1300%
EPS Next 2Y146.58%
EPS Next 3Y-12.4%
EPS Next 5Y70.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BSX.CA Yearly Revenue VS EstimatesBSX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2022 2023 2024 2M 4M 6M
BSX.CA Yearly EPS VS EstimatesBSX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.05 -0.05 0.1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BSX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 4.97, the valuation of BSX can be described as very cheap.
96.29% of the companies in the same industry are more expensive than BSX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.41, BSX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.97
BSX.CA Price Earnings VS Forward Price EarningsBSX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSX.CA Per share dataBSX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

BSX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as BSX's earnings are expected to decrease with -12.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y146.58%
EPS Next 3Y-12.4%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BSX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELO SUN MINING CORP

TSX:BSX (6/16/2025, 7:00:00 PM)

0.205

-0.01 (-2.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04
Inst Owners9.66%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap95.68M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.97
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.04
P/tB 5.04
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)0.04
Fwd EY20.1%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.63%
ROE -47.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.85%
ROA(5y)-26.09%
ROE(3y)-38.88%
ROE(5y)-28.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.23
Quick Ratio 3.23
Altman-Z 1.63
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)30.99%
Cap/Depr(5y)27.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
EPS Next Y1300%
EPS Next 2Y146.58%
EPS Next 3Y-12.4%
EPS Next 5Y70.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2224.4%
EBIT Next 3Y1.77%
EBIT Next 5Y118.42%
FCF growth 1Y33.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.66%
OCF growth 3YN/A
OCF growth 5YN/A